SciClone (SCLN) Notes Possible Q1 Revenue Impact Due to NovaMed Accounting

(Source: StreetInsider) Today, we are reporting preliminary results assuming an accounting basis  licensing agreement with Zensun (Shanghai) Science & Technology for Neucardin”,